13th Annual Biomarkers Congress | Manchester, UK
Metabolon is a sponsor of the Biomarkers Congress being held in Manchester, UK from February 15-16, 2018. You’ll find us at booth #15.
Also, please join us for our podium presentation:
Metabolomics as a Leading Technology in Biomarker Discovery
Thursday, February 15, 2018
Presented by Brian Keppler, PhD
Associate Director, Project Management, Metabolon, Inc.
Join us for this informative presentation where we’ll discuss how:
- Metabolites are sensitive indicators of homeostatic changes and are tightly coupled to the phenotype, making them excellent candidates for biomarkers. Metabolites also play a crucial role in the signaling and regulation of genes, proteins and microbiota, making metabolomics an ideal complement for other forms of ‘omics research.
- Metabolomics is a powerful tool and has emerged as a leading technology for biomarker discovery to facilitate early diagnosis of disease, prediction of disease progression, monitoring/predicting patient responses to medicines, identification of new drug targets and toxicity profiles.
- Metabolon is an accomplished leader in the field of metabolomics. Our metabolomics services rage from broad to targeted and are commonly utilized within a variety of applications across diverse areas of research in discovery biology, pharmaceutical R&D, clinical trials, nutrition, bioprocessing and cell culture science.
Manchester Central Convention Complex
Manchester M2 3GX